Bank of America’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,413
| Closed | -$1.48K | – | 6581 |
|
|
2025
Q4 | $1.48K | Buy |
1,413
+13
| +0.9% | +$21 | ﹤0.01% | 6436 |
|
|
2025
Q3 | $3.47K | Buy |
1,400
+1,354
| +2,943% | +$3.08K | ﹤0.01% | 7345 |
|
|
2025
Q2 | $108 | Buy |
46
+5
| +12% | +$10 | ﹤0.01% | 7957 |
|
|
2025
Q1 | $53 | Buy |
41
+34
| +486% | +$63 | ﹤0.01% | 7974 |
|
|
2024
Q4 | $13 | Hold |
7
| – | – | ﹤0.01% | 8071 |
|
|
2024
Q3 | $24 | Buy |
7
+3
| +75% | +$11 | ﹤0.01% | 7943 |
|
|
2024
Q2 | $26 | Buy |
+4
| New | +$26 | ﹤0.01% | 7957 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8638 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | -$159 | – | 8538 |
|
|
2021
Q3 | $0 | Buy |
+1
| New | +$209 | ﹤0.01% | 8314 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7298 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7109 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 7052 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 7144 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7317 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7439 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7354 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7343 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7311 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7137 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7262 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7277 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7186 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7211 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7112 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6866 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6919 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6951 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6901 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6574 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7100 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6971 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6970 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6303 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6752 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6864 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6777 |
|
Other funds holding PHIO
VCM
VFT
HF
SRL
XT
Bank of America's PHIO Position: Q1 2026 in Review
Bank of America sold out of Phio Pharmaceuticals (PHIO) in Q1 2026, closing a stake of 1,413 shares — an estimated $1.48K sold.
Bank of America first reported a position in PHIO in Q3 2021 and held it in 8 quarters. The position peaked at $3.47K in Q3 2025. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.
- Bank of America reported no remaining Phio Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 1,413 Phio Pharmaceuticals shares in Q1 2026, an estimated $1.48K.
- Bank of America first reported a position in Phio Pharmaceuticals in Q3 2021 and held it in 8 quarters.
- Bank of America's Phio Pharmaceuticals position peaked at $3.47K in Q3 2025.
- 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.